• 1
    Li X, Wang L, Zhong Y et al. Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients. J Clin Microbio 2010; 48:43634369.
  • 2
    Wu W, Shi Y, Li SP et al. Blockade of Tim-3 signaling restores the virus-specific CD8+ T-cell response in patients with chronic hepatitis B. Eur J Immunol 2012; 42:11801191.
  • 3
    European Association for the Study of the Liver (EASL). EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009; 50:227242.
  • 4
    McMahon BJ. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int 2009; 3:334342.
  • 5
    Zhong YW, Han JQ, Zou ZS et al. Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR. Clin Chim Acta 2011; 412:19051911.
  • 6
    Jonas MM, Block JM, Haber BA et al. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology 2010; 52:21922205.
  • 7
    Nebbia G, Peppa D, Maini MK. Hepatitis B infection: current concepts and future challenges. Q J Med 2012; 105:109113.
  • 8
    Chu CM, Liaw YF. Hepatitis B surface antigen seroclearance during chronic HBV infection. Antivir Ther 2010; 15:133143.
  • 9
    Adams DH, Ju C, Ramaiah SK, Uetrecht J, Jaeschke H. Mechanisms of immune-mediated liver injury. Toxicol Sci 2010; 15:307321.
  • 10
    Park O, Jeong WI, Wang L et al. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology 2009; 49:16831694.
  • 11
    Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol 2011; 26:173179.
  • 12
    Ye YF, Xie XJ, Yu JW et al. Involvement of Th17 and Th1 effector responses in patients with hepatitis B. J Clin Immunol 2010; 30:546555.
  • 13
    Hammerich L, Heymann F, Tacke F. Role of IL-17 and Th17 cells in liver. Dis Clin Dev Immunol 2011; doi:10.1155/2011/345803.
  • 14
    Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol 2006; 6:329334.
  • 15
    Wu W, Li J, Chen F et al. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol 2010; 25:750757.
  • 16
    Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev 2008; 7:87113.
  • 17
    Akdis M, Blaser K, Akdis CA. T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 2005; 116:961968.
  • 18
    Kristine K, Liu L, Song QN, Jonathon D. The IL-23/Th17 axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol 2006; 18:670675.
  • 19
    Wilke CM, Bishop K, Fox D, Zou W. Deciphering the role of Th17 cells in human disease. Trends Immunol 2011; 32:603611.
  • 20
    Zhang JY, Zhang Z, Lin F et al. Interleukin-17-producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010; 51:8191.
  • 21
    Zhong YW, Li J, Song HB et al. Virologic and clinical characteristics of HBV genotypes/subgenotypes in 487 Chinese pediatric patients with CHB. BMC Infect 2011; 11:262267.
  • 22
    Liu Y, Wang C, Zhong Y et al. Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection. J Viral Hepat 2011; 18:2939.
  • 23
    Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49:13351374.
  • 24
    Chinese Society of Infectious Diseases and Parasitology, Chinese Society of Hepatology. Management scheme of diagnostic and therapy criteria of viral hepatitis. Chin J Hepatol 2000; 6:324329.
  • 25
    Lohse AW, Mieli-Vergani G. Autoimmune hepatitis. J Hepatol 2011; 55:171182.
  • 26
    China-CDC, China Ministry of Health. UN theme group on HIV/AIDS in China. Beijing: China-CDC, China Ministry of Health, 2003.
  • 27
    Zhong YW, Lv JY, Li J et al. Virology and antiviral drugs susceptibility of hepatitis B virus rtN238H polymerase mutation from 1865 Chinese patients with chronic hepatitis B. Antivir Res 2012; 93:185190.
  • 28
    Jia S, Li C, Wang G, Yang J, Zu Y. The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin Exp Immunol 2010; 162:131137.
  • 29
    Ivanov II, McKenzie BS, Zhou L et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17-T helper cells. Cell 2006; 126:11211133.
  • 30
    Tonetto PA, Gonçales NS, Fais VC et al. Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of Brazil. BMC Infect 2009; 9:149155.
  • 31
    Wang LY, Chen SJ, Xu KS. IL-17 expression is correlated with hepatitis B-related liver diseases and fibrosis. Int J Mol Med 2011; 27:385392.
  • 32
    Zhang Z, Chen D, Yao J et al. Increased infiltration of intrahepatic DC subsets closely correlate with viral control and liver injury in immune active pediatric patients with chronic hepatitis B. Clin Immunol 2007; 122:173180.
  • 33
    Hamada S, Umemura M, Shiono T et al. IL-17 a produced by γδT cells plays a critical role in innate immunity against Listeria monocytogenes infection in the liver. J Immunol 2008; 181:34563463.